VTN and myeloid sarcoma: Myelin staining for complement proteins has been suggested to be a non-specific feature [12]; however, using double immunolabelling we found complement markers co-localized in areas of degenerating myelin and damaged axons in MS sections (Figures 4 and 5), implicating complement in axonal and myelin injury in and around active and chronic plaques.